Text Correction
There was an error in the original article [1]. In the Abstract, page 1, line 12 from the top, the sentence “… remdesivir, a nucleotide analog that acts as reverse-transcriptase inhibitor, …” is incorrect.
A correction has been made to the Abstract.
The incorrect sentence must be replaced with “… remdesivir, a nucleotide analog that acts as RNA-dependent RNA-polymerase inhibitor, …”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Reference
- Zanella, I.; Zizioli, D.; Castelli, F.; Quiros-Roldan, E. Tenofovir, another inexpensive, well-known and widely available old drug repurposed for SARS-COV-2 infection. Pharmaceuticals 2021, 14, 454. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).